Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors
Gespeichert in:
| Veröffentlicht in: | British journal of dermatology (1951) 2015-06, Vol.172 (6), p.1680-1682 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1682 |
|---|---|
| container_issue | 6 |
| container_start_page | 1680 |
| container_title | British journal of dermatology (1951) |
| container_volume | 172 |
| creator | Vigarios, E. Lamant, L. Delord, J.P. Fricain, J.C. Chevreau, C. Barrés, B. Gomez-Roca, C. Boulanger, M. Sibaud, V. |
| description | |
| doi_str_mv | 10.1111/bjd.13610 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2190232455</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2190232455</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4610-5d52689e9f52b6cda7a629e087d1f8ba1cd0c3c5ff4dd053a1093bbe7d42aae43</originalsourceid><addsrcrecordid>eNp1kMtOwzAQRS0EouWx4AeQJVYs0o7tOI8lFCiPikoIVImN5diO6pImrZ0I-vcE0rJjNrM598zoInRGYEDaGWYLPSAsIrCH-u3mASWM7aM-AMQBpBHroSPvFwCEAYdD1KM8TDkNoz6aTJ0ssF83clk1HitTFFhJp2xZLSWWpcbzzcq4D-NkXdVW4cJ4W5Uef9p6jq9fru6wLec2s3Xl_Ak6yGXhzel2H6O3u9vX0X0wmY4fRleTQIXtkwHXnEZJatKc0yxSWsYyoqmBJNYkTzJJlAbFFM_zUGvgTBJIWZaZWIdUShOyY3TReVeuWjfG12JRNa5sTwpKUqCMhpy31GVHKVd570wuVs4updsIAuKnN9H2Jn57a9nzrbHJlkb_kbuiWmDYAZ-2MJv_TeL68WanDLqE9bX5-ktI9yGimMVczJ7HIgmT2QTeX8QT-wa-nIX8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2190232455</pqid></control><display><type>article</type><title>Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Vigarios, E. ; Lamant, L. ; Delord, J.P. ; Fricain, J.C. ; Chevreau, C. ; Barrés, B. ; Gomez-Roca, C. ; Boulanger, M. ; Sibaud, V.</creator><creatorcontrib>Vigarios, E. ; Lamant, L. ; Delord, J.P. ; Fricain, J.C. ; Chevreau, C. ; Barrés, B. ; Gomez-Roca, C. ; Boulanger, M. ; Sibaud, V.</creatorcontrib><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1111/bjd.13610</identifier><identifier>PMID: 25495246</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Antineoplastic Agents - adverse effects ; Carcinoma, Squamous Cell - chemically induced ; Humans ; Imidazoles - adverse effects ; Indoles - adverse effects ; Leukoplakia, Oral - chemically induced ; Melanoma - drug therapy ; Middle Aged ; Mouth Mucosa ; Mouth Neoplasms - chemically induced ; Mutation - genetics ; Oral cancer ; Oral squamous cell carcinoma ; Oximes - adverse effects ; Proto-Oncogene Proteins B-raf - genetics ; Skin Neoplasms - drug therapy ; Squamous cell carcinoma ; Sulfonamides - adverse effects ; Vemurafenib</subject><ispartof>British journal of dermatology (1951), 2015-06, Vol.172 (6), p.1680-1682</ispartof><rights>2014 British Association of Dermatologists</rights><rights>Copyright © 2015 British Association of Dermatologists</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4610-5d52689e9f52b6cda7a629e087d1f8ba1cd0c3c5ff4dd053a1093bbe7d42aae43</citedby><cites>FETCH-LOGICAL-c4610-5d52689e9f52b6cda7a629e087d1f8ba1cd0c3c5ff4dd053a1093bbe7d42aae43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjd.13610$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjd.13610$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25495246$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vigarios, E.</creatorcontrib><creatorcontrib>Lamant, L.</creatorcontrib><creatorcontrib>Delord, J.P.</creatorcontrib><creatorcontrib>Fricain, J.C.</creatorcontrib><creatorcontrib>Chevreau, C.</creatorcontrib><creatorcontrib>Barrés, B.</creatorcontrib><creatorcontrib>Gomez-Roca, C.</creatorcontrib><creatorcontrib>Boulanger, M.</creatorcontrib><creatorcontrib>Sibaud, V.</creatorcontrib><title>Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors</title><title>British journal of dermatology (1951)</title><addtitle>Br J Dermatol</addtitle><subject>Adult</subject><subject>Aged</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Carcinoma, Squamous Cell - chemically induced</subject><subject>Humans</subject><subject>Imidazoles - adverse effects</subject><subject>Indoles - adverse effects</subject><subject>Leukoplakia, Oral - chemically induced</subject><subject>Melanoma - drug therapy</subject><subject>Middle Aged</subject><subject>Mouth Mucosa</subject><subject>Mouth Neoplasms - chemically induced</subject><subject>Mutation - genetics</subject><subject>Oral cancer</subject><subject>Oral squamous cell carcinoma</subject><subject>Oximes - adverse effects</subject><subject>Proto-Oncogene Proteins B-raf - genetics</subject><subject>Skin Neoplasms - drug therapy</subject><subject>Squamous cell carcinoma</subject><subject>Sulfonamides - adverse effects</subject><subject>Vemurafenib</subject><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtOwzAQRS0EouWx4AeQJVYs0o7tOI8lFCiPikoIVImN5diO6pImrZ0I-vcE0rJjNrM598zoInRGYEDaGWYLPSAsIrCH-u3mASWM7aM-AMQBpBHroSPvFwCEAYdD1KM8TDkNoz6aTJ0ssF83clk1HitTFFhJp2xZLSWWpcbzzcq4D-NkXdVW4cJ4W5Uef9p6jq9fru6wLec2s3Xl_Ak6yGXhzel2H6O3u9vX0X0wmY4fRleTQIXtkwHXnEZJatKc0yxSWsYyoqmBJNYkTzJJlAbFFM_zUGvgTBJIWZaZWIdUShOyY3TReVeuWjfG12JRNa5sTwpKUqCMhpy31GVHKVd570wuVs4updsIAuKnN9H2Jn57a9nzrbHJlkb_kbuiWmDYAZ-2MJv_TeL68WanDLqE9bX5-ktI9yGimMVczJ7HIgmT2QTeX8QT-wa-nIX8</recordid><startdate>201506</startdate><enddate>201506</enddate><creator>Vigarios, E.</creator><creator>Lamant, L.</creator><creator>Delord, J.P.</creator><creator>Fricain, J.C.</creator><creator>Chevreau, C.</creator><creator>Barrés, B.</creator><creator>Gomez-Roca, C.</creator><creator>Boulanger, M.</creator><creator>Sibaud, V.</creator><general>Blackwell Publishing Ltd</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>201506</creationdate><title>Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors</title><author>Vigarios, E. ; Lamant, L. ; Delord, J.P. ; Fricain, J.C. ; Chevreau, C. ; Barrés, B. ; Gomez-Roca, C. ; Boulanger, M. ; Sibaud, V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4610-5d52689e9f52b6cda7a629e087d1f8ba1cd0c3c5ff4dd053a1093bbe7d42aae43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Carcinoma, Squamous Cell - chemically induced</topic><topic>Humans</topic><topic>Imidazoles - adverse effects</topic><topic>Indoles - adverse effects</topic><topic>Leukoplakia, Oral - chemically induced</topic><topic>Melanoma - drug therapy</topic><topic>Middle Aged</topic><topic>Mouth Mucosa</topic><topic>Mouth Neoplasms - chemically induced</topic><topic>Mutation - genetics</topic><topic>Oral cancer</topic><topic>Oral squamous cell carcinoma</topic><topic>Oximes - adverse effects</topic><topic>Proto-Oncogene Proteins B-raf - genetics</topic><topic>Skin Neoplasms - drug therapy</topic><topic>Squamous cell carcinoma</topic><topic>Sulfonamides - adverse effects</topic><topic>Vemurafenib</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vigarios, E.</creatorcontrib><creatorcontrib>Lamant, L.</creatorcontrib><creatorcontrib>Delord, J.P.</creatorcontrib><creatorcontrib>Fricain, J.C.</creatorcontrib><creatorcontrib>Chevreau, C.</creatorcontrib><creatorcontrib>Barrés, B.</creatorcontrib><creatorcontrib>Gomez-Roca, C.</creatorcontrib><creatorcontrib>Boulanger, M.</creatorcontrib><creatorcontrib>Sibaud, V.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vigarios, E.</au><au>Lamant, L.</au><au>Delord, J.P.</au><au>Fricain, J.C.</au><au>Chevreau, C.</au><au>Barrés, B.</au><au>Gomez-Roca, C.</au><au>Boulanger, M.</au><au>Sibaud, V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors</atitle><jtitle>British journal of dermatology (1951)</jtitle><addtitle>Br J Dermatol</addtitle><date>2015-06</date><risdate>2015</risdate><volume>172</volume><issue>6</issue><spage>1680</spage><epage>1682</epage><pages>1680-1682</pages><issn>0007-0963</issn><eissn>1365-2133</eissn><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>25495246</pmid><doi>10.1111/bjd.13610</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-0963 |
| ispartof | British journal of dermatology (1951), 2015-06, Vol.172 (6), p.1680-1682 |
| issn | 0007-0963 1365-2133 |
| language | eng |
| recordid | cdi_proquest_journals_2190232455 |
| source | MEDLINE; Access via Wiley Online Library; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Adult Aged Antineoplastic Agents - adverse effects Carcinoma, Squamous Cell - chemically induced Humans Imidazoles - adverse effects Indoles - adverse effects Leukoplakia, Oral - chemically induced Melanoma - drug therapy Middle Aged Mouth Mucosa Mouth Neoplasms - chemically induced Mutation - genetics Oral cancer Oral squamous cell carcinoma Oximes - adverse effects Proto-Oncogene Proteins B-raf - genetics Skin Neoplasms - drug therapy Squamous cell carcinoma Sulfonamides - adverse effects Vemurafenib |
| title | Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T18%3A21%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20squamous%20cell%20carcinoma%20and%20hyperkeratotic%20lesions%20with%20BRAF%20inhibitors&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=Vigarios,%20E.&rft.date=2015-06&rft.volume=172&rft.issue=6&rft.spage=1680&rft.epage=1682&rft.pages=1680-1682&rft.issn=0007-0963&rft.eissn=1365-2133&rft_id=info:doi/10.1111/bjd.13610&rft_dat=%3Cproquest_cross%3E2190232455%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2190232455&rft_id=info:pmid/25495246&rfr_iscdi=true |